Superior vena cava syndrome associated with Behcet's disease and 18 months' follow up: A case report

Rheumatology International

Volumn 28, Issue 8, 2008, Pages 807-809

  Sezer, Ilhan ^a   Melikoglu, M Alkan ^a   Çay, H Fatih ^a   Kocabaş, Hilal ^a   Bütün, Bülent ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Behcet's disease; Superior vena cava syndrome

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HLA B51 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; STEROID;

ADULT; ANAMNESIS; ARM; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FACE; FOLLOW UP; GENITAL ULCER; HUMAN; JUGULAR VEIN; MALE; MOUTH ULCER; NECK; PATIENT REFERRAL; PHLEBOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SUBCLAVIAN VEIN; SUPERIOR CAVA VEIN SYNDROME; UVEITIS; VEIN DILATATION; VENOUS THROMBOEMBOLISM; VISUAL IMPAIRMENT;

ADULT; ANGIOGRAPHY; BEHCET SYNDROME; CONSTRICTION, PATHOLOGIC; FOLLOW-UP STUDIES; HUMANS; MALE; SUPERIOR VENA CAVA SYNDROME; TIME FACTORS;

EID: 43449135626     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0517-8     Document Type: Article

References (12)

1. Marshall Sara E (2004) Behçet's disease. Best Pract Res Clin Rheumatol 18:291-311
2. Yazici H, Yurdakul S, Hamuryudan V, Fresko İ (2003) Behçet's syndrome In: Hochberg MC et al (eds) Rheumatology, 3rd edn. Mosby, London, pp 1665-1669
3. Kuzu MA, Ozaslan C, Koksoy C, Gurler A, Tuzuner A (1994) Vascular involvement in Behcet's disease: 8-year audit. World J Surg 18:948-953
4. Reechaipichitkul W, Thongpaen S (2004) Etiology and outcome of superior vena cava (SVC) obstruction in adults. Southeast Asian J Trop Med Public Health 35:453-457
5. Hamuryudan V, Er T, Seyahi E, Akman C, Tuzun H, Fresko I et al (2004) Pulmonary artery aneurysms in Behçet syndrome. Am J Med 117:867-870
6. Barnes CG (2006) Treatment of behçet's syndome. Rheumatology 45:245-247
7. YazIcI H (2002) Behçet's syndrome: where do we stand. Am J Med 112:75-76
8. Probst K, Fijnheer R, Rothova A (2004) Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Am J Ophthalmol 137:850-857
9. Arayssi T, Hamdan A (2004) New insights into the pathogenesis and therapy of Behçet's disease. Curr Opin Pharmacol 4:183-188
10. Houman MH, Hamzaoui K (2006) Promising new therapies for Behcet's disease. Eur J Inter Med 17:163-169
11. Hanta İ, Ucar G, Kuleci S, Özbek S, Kocabaş A (2005) Superior vena cava syndrome: a rare clinical manifastation of Behçet's disease. Clin Rheumatol 24:314-315
12. Castelli P, Caronno R, Piffaretti G, Tozzi M, Lomazzi C et al (2005) Endovascular treatment for superior vena cava obstruction in Behçet disease. J Vasc Surg 41:548-551